FindTrial
Sign In

A medical records based study for the efficacy of integrated Chinese and western medicine in the treatment of acute pancreatitis

The efficacy of integrated Chinese and western medicine in the treatment of acute pancreatitis in the real world

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033579
Enrollment
Unknown
Registered
2020-06-06
Start date
2020-01-01
Completion date
Unknown
Last updated
2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

Integrated traditional Chinese and western medicine treatment group:Integrated traditional Chinese and western medicine treatment
Western medicine treatment group:Western medicine treatment

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years; 2. Meet the diagnostic criteria for AP; 3. Onset to admission within 48 hours.

Exclusion criteria

Exclusion criteria: 1. pregnant or nursing women; 2. Patients with any history of tumor disease; 3. Patients with advanced or terminal stages of any disease.

Design outcomes

Primary

MeasureTime frame
Shortened duration of organ failure in AP patients;—

Secondary

MeasureTime frame
mortality;the incidence of organ failure;The incidence of local pancreatic complications;Infection rate of pancreatic necrosis;Rate of surgery;treatment cost;The length of stay;Length of stay in ICU;—

Countries

China

Contacts

Public ContactQing Xia

West China Hospital, Sichuan University

xiaqing@medmail.com.cn+86 18980601723

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026